相关实验视频

Updated: Jan 12, 2026

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

帕拉托普可塑性决定了抗HER2 (4B5) 抗体的特异性

P Daniel Warren¹, Terry H Landowski¹, Mark S Dodson¹

¹Assay Development, Roche Tissue Diagnostics, Tucson, AZ, USA.

|November 7, 2025

概括

PATHWAY抗HER2/neu (4B5) 抗体可以与HER4,ZSCAN18和阿尔多基因还原酶家族蛋白质进行交叉反应. 这种非目标结合可以在免疫组织化学 (IHC) 试验中引起意想不到的细胞质和核染色.

科学领域:

免疫组织化学免疫组织化学
分子生物学分子生物学
蛋白质化学蛋白质化学

背景情况:

PATHWAY抗HER2/neu (4B5) 抗体对于识别符合抗HER2向治疗条件的患者至关重要.
之前的研究表明,在实验条件下,4B5抗体与HER4和ZSCAN18的潜在交叉反应.

研究的目的:

为了充分描述4B5抗体的表位和结合特性.
为了确定负责观察到非乳腺组织中细胞质和核反应性的非标蛋白质.
定义非目标相互作用的绑定特性和检测极限.

主要方法:

表面等离子体共振 (SPR) 是一种
自动毛细血管电泳 (ACE) 技术
免疫组织化学 (IHC)
蛋白质净化蛋白质的净化
质谱测量质量谱测量
在体内进行对接分析.

主要成果:

确定了参与4B5抗体识别的关键氨基酸.
发现4B5抗体与阿尔多基因还原酶家族1成员B1,B10和B15 (AKR1B1,AKR1B10,AKR1B15) 发生交叉反应.
确定了这些非目标相互作用的约束特征和检测极限.
在体分析显示了帕拉托普可塑性,可以与AKR1B家族蛋白质相互作用,这是由于互补性决定区域循环的灵活性.

结论:

4B5抗体表现出与AKR1B家族蛋白质的脱结合,有助于细胞质和核IHC染色.
了解这些非目标相互作用对于准确解释IHC结果和为目标治疗选择患者至关重要.
标志性表位和结合性质为改善抗体特异性或开发替代诊断工具提供了基础.

关键词:

在HER2生物标志物中,HER2是生物标志物.标本地图绘制标本地图绘制免疫组织化学免疫组织化学分子建模分子建模表面的等离子体共振.

更多相关视频

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Diversity of Antigen Receptors

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...

Cross-reactivity

Cross-reactivity